Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults.
Erondu N, Gantz I, Musser B, Suryawanshi S, Mallick M, Addy C, Cote J, Bray G, Fujioka K, Bays H, Hollander P, Sanabria-Bohórquez SM, Eng W, Långström B, Hargreaves RJ, Burns HD, Kanatani A, Fukami T, MacNeil DJ, Gottesdiener KM, Amatruda JM, Kaufman KD, Heymsfield SB.
Erondu N, et al. Among authors: mallick m.
Cell Metab. 2006 Oct;4(4):275-82. doi: 10.1016/j.cmet.2006.08.002.
Cell Metab. 2006.
PMID: 17011500
Free article.
Clinical Trial.